Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Predictive Modeling of Anal Dysplasia Progression in HIV
Status: Enrolling
Updated:  10/16/2012
University of Cincinnati
mi
from
Cincinnati, OH
Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Predictive Modeling of Anal Dysplasia Progression in HIV
Status: Enrolling
Updated: 10/16/2012
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated:  10/17/2012
Miami Pediatric Gastroenterology
mi
from
Miami, FL
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated: 10/17/2012
Miami Pediatric Gastroenterology
mi
from
Miami, FL
Click here to add this to my saved trials
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated:  10/17/2012
University of Texas School of Public Health
mi
from
El Paso, TX
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated: 10/17/2012
University of Texas School of Public Health
mi
from
El Paso, TX
Click here to add this to my saved trials
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated:  10/17/2012
Baylor College of Medicine
mi
from
Houston, TX
POCone-UBiT-IR300 Pediatric Comparison Study
A Prospective, Multi-Center, Open-Label Study to Compare the POCone® With the Ubit®-IR300 in Measurement of 13CO2/12CO2 Ratio in Breath Samples Collected From Pediatric Subjects Ages 3 to 17 Years With Upper Gastrointestinal Signs and Symptoms
Status: Enrolling
Updated: 10/17/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of Macrolide Immunomodulation in Severe Sepsis.
Efficacy of Macrolide Immunomodulation in Severe Sepsis
Status: Enrolling
Updated:  10/18/2012
VA South Texas Health Care System, San Antonio
mi
from
San Antonio, TX
Efficacy of Macrolide Immunomodulation in Severe Sepsis.
Efficacy of Macrolide Immunomodulation in Severe Sepsis
Status: Enrolling
Updated: 10/18/2012
VA South Texas Health Care System, San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
MCS Clinical Trials
mi
from
Los Angeles, CA
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
MCS Clinical Trials
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
Sunshine Research Center
mi
from
Opa-Locka, FL
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Sunshine Research Center
mi
from
Opa-Locka, FL
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
Altus Rsearch,INC
mi
from
West Palm Beach, FL
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Altus Rsearch,INC
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
Provident Clincal Research
mi
from
Addison, IL
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Provident Clincal Research
mi
from
Addison, IL
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
Central Kentucky Research
mi
from
Lexington, KY
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Central Kentucky Research
mi
from
Lexington, KY
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
Rochester Clinical Research
mi
from
Irondequoit, NY
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Rochester Clinical Research
mi
from
Irondequoit, NY
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
PGM Research of Winston-Salem, LLC
mi
from
Winston-Salem, NC
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
PGM Research of Winston-Salem, LLC
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
Clinical Partners, LLC
mi
from
Johnston, RI
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
Corsicana Medical Research,PNC
mi
from
Corsicana, TX
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
Corsicana Medical Research,PNC
mi
from
Corsicana, TX
Click here to add this to my saved trials
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated:  10/22/2012
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status: Enrolling
Updated: 10/22/2012
National Clinical Research - Richmond, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated:  10/25/2012
Westover Heights Clinic
mi
from
Portland, OR
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated: 10/25/2012
Westover Heights Clinic
mi
from
Portland, OR
Click here to add this to my saved trials
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated:  10/25/2012
Center for Clinical Studies, Texas Medical Center
mi
from
Houston, TX
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated: 10/25/2012
Center for Clinical Studies, Texas Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated:  10/25/2012
Center for Clinical Studies- Webster
mi
from
Houston, TX
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated: 10/25/2012
Center for Clinical Studies- Webster
mi
from
Houston, TX
Click here to add this to my saved trials
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated:  10/25/2012
Center for Clinical Studies - Cypress
mi
from
Houston, TX
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated: 10/25/2012
Center for Clinical Studies - Cypress
mi
from
Houston, TX
Click here to add this to my saved trials
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated:  10/25/2012
University of Washington Virology Research Clinic
mi
from
Seattle, WA
Biological Efficacy Study of HerpV Vaccine With QS-21 to Treat Subjects With Recurrent Genital Herpes
A Phase 2a Multicenter, Double-blinded, Randomized Trial to Evaluate The Effect of HerpV on Viral Shedding in Adults With Recurrent Genital Herpes
Status: Enrolling
Updated: 10/25/2012
University of Washington Virology Research Clinic
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Human Parainfluenza Type 1 Virus Vaccine, rHPIV1 84/del170/942A, Lot PIV1 #104A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV1-Seropositive Children 15 to 59 Months of Age, and HPIV1-Seronegative Infants and Children 6 to 59 Months of Age
Status: Enrolling
Updated:  10/26/2012
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Safety of and Immune Response to Recombinant Live-Attenuated Parainfluenza Type 1 Virus Vaccine
A Phase I Study of the Safety and Immunogenicity of the Recombinant Live-Attenuated Human Parainfluenza Type 1 Virus Vaccine, rHPIV1 84/del170/942A, Lot PIV1 #104A, Delivered as Nose Drops to Adults 18 to 49 Years of Age, HPIV1-Seropositive Children 15 to 59 Months of Age, and HPIV1-Seronegative Infants and Children 6 to 59 Months of Age
Status: Enrolling
Updated: 10/26/2012
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
Conventional Therapy vs Sequential Therapy for the Treatment of Helicobacter Pylori Infection
Status: Enrolling
Updated:  11/5/2012
Dallas VAMC
mi
from
Dallas, TX
Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection
Conventional Therapy vs Sequential Therapy for the Treatment of Helicobacter Pylori Infection
Status: Enrolling
Updated: 11/5/2012
Dallas VAMC
mi
from
Dallas, TX
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Palms of Pasadena Hospital
mi
from
St. Petersburg, FL
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Palms of Pasadena Hospital
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Bayfront Wound Care & Hyperbaric
mi
from
St. Petersburg, FL
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Bayfront Wound Care & Hyperbaric
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
St. Joseph's Baycare Wound Care & Hyperbaric
mi
from
Tampa, FL
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
St. Joseph's Baycare Wound Care & Hyperbaric
mi
from
Tampa, FL
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
LSU Health Sciences Center
mi
from
Shreveport, LA
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
LSU Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Bayshore Community Hospital
mi
from
Holmdel, NJ
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Bayshore Community Hospital
mi
from
Holmdel, NJ
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Wound Institute & Research Center
mi
from
Dunmore, PA
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Wound Institute & Research Center
mi
from
Dunmore, PA
Click here to add this to my saved trials
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated:  11/7/2012
Lake Washington Vascular Surgeons
mi
from
Bellevue, WA
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Restore Calcium Alginate Dressing, Silver vs Aquacel Ag in the Treatment of Critically Colonized Venous Leg Ulcers
Status: Enrolling
Updated: 11/7/2012
Lake Washington Vascular Surgeons
mi
from
Bellevue, WA
Click here to add this to my saved trials
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
A Case Series of Ceftaroline-treated Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline, Compared to Vancomycin-treated Patients
Status: Enrolling
Updated:  11/7/2012
Erie County Medical Center
mi
from
Buffalo, NY
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
A Case Series of Ceftaroline-treated Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline, Compared to Vancomycin-treated Patients
Status: Enrolling
Updated: 11/7/2012
Erie County Medical Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Status: Enrolling
Updated:  11/13/2012
Columbia University Medical Center
mi
from
New York, NY
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Aggressive Fever Control With Intravenous Ibuprofen After Non-traumatic Brain Hemorrhage
Status: Enrolling
Updated: 11/13/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Univ. of Alabama Birmingham NICHD CRS (5096)
mi
from
Birmingham, AL
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Univ. of Alabama Birmingham NICHD CRS (5096)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
University of South Alabama
mi
from
Mobile, AL
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
University of South Alabama
mi
from
Mobile, AL
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Phoenix Childrens Hospital
mi
from
Phoenix, AZ
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Phoenix Childrens Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Long Beach Memorial (Pediatric)
mi
from
Long Beach, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Long Beach Memorial (Pediatric)
mi
from
Long Beach, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Miller Children's Hospital Long Beach (5093)
mi
from
Long Beach, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Miller Children's Hospital Long Beach (5093)
mi
from
Long Beach, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601)
mi
from
Los Angeles, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CR (3601)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Usc La Nichd Crs (5048)
mi
from
Los Angeles, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Usc La Nichd Crs (5048)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
UCLA Med Ctr / Pediatric
mi
from
Los Angeles, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
UCLA Med Ctr / Pediatric
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Los Angeles County Medical Center/USC
mi
from
Los Angeles, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Los Angeles County Medical Center/USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Univ of California, San Diego (4601)
mi
from
San Diego, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Univ of California, San Diego (4601)
mi
from
San Diego, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Univ. of California San Francisco NICHD CRS (5091)
mi
from
San Francisco,, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Univ. of California San Francisco NICHD CRS (5091)
mi
from
San Francisco,, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Harbor-UCLA Med Ctr (5045)
mi
from
Torrance, CA
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Harbor-UCLA Med Ctr (5045)
mi
from
Torrance, CA
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
University of Colorado Denver NICHD CRS (5052)
mi
from
Denver, CO
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
University of Colorado Denver NICHD CRS (5052)
mi
from
Denver, CO
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Connecticut Childrens Medical Center (Pediatric)
mi
from
Farmington, CT
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Connecticut Childrens Medical Center (Pediatric)
mi
from
Farmington, CT
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
University of Connecticut, Farmington
mi
from
Farmington, CT
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
University of Connecticut, Farmington
mi
from
Farmington, CT
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Yale Univ School of Med
mi
from
New Haven, CT
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Yale Univ School of Med
mi
from
New Haven, CT
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Washington Hospital Center NICHD CRS (5023)
mi
from
Washington,
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Washington Hospital Center NICHD CRS (5023)
mi
from
Washington,
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Howard Univ Hosp (5044)
mi
from
Washington,
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Howard Univ Hosp (5044)
mi
from
Washington,
Click here to add this to my saved trials
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated:  11/15/2012
Children's National Medical Center Washington DC NICHD CRS (5015)
mi
from
Washington,
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission
Perinatal Core Protocol
Status: Enrolling
Updated: 11/15/2012
Children's National Medical Center Washington DC NICHD CRS (5015)
mi
from
Washington,
Click here to add this to my saved trials